Continuing Medical Education: Neurology and Primary Care CME 2011: Connecting the Dots in Antipsychotic Maintenance Therapy: CME Outfitters: Live Broadcast: October 5, 2011
Connecting the Dots in Antipsychotic Maintenance Therapy
CME Sponsor:
CME Outfitters
Location:
Online
Course faculty:
Henry A. Nasrallah, MD (Moderator)
Professor of Psychiatry and Neuroscience
University of Cincinnati College of Medicine
Cincinnati, OH
Leslie Citrome, MD, MPH
Professor, Department of Psychiatry
NYU Medical Center
New York, NY
Diana O. Perkins, MD, MPH
Professor, Department of Psychiatry
Medical Director, Outreach and Support Intervention Services (OASIS)
University of North Carolina
Chapel Hill, NC
Number of Credits:
1.0 AMA PRA Category 1 Credit™
Link
Detailed Description:
This neuroscience CME Live and On Demand activity will support clinicians to become increasingly proactive in managing adherence and in monitoring their patients with schizophrenia for both clinical progress and optimal outcome. The goal is to implement actionable strategies to integrate measurement-based care and improve adherence to antipsychotic medications. This educational activity is intended for physicians, physician assistants, nurses, nurse practitioners, pharmacists, psychologists, social workers, certified case managers, and other nonphysician health care professionals with an interest in schizophrenia.
Learning Objectives:
At the end of this CME/CE activity, participants should be able to:
• Define the critical areas that affect nonadherence to antipsychotic medication and implement strategies to address adherence in patients with schizophrenia.
• Review the available tools to evaluate patients’ progress and implement regular, measurement-based evaluations.
• Implement regular metabolic screening for patients taking antipsychotic medication.
The following learning objectives pertain only to those requesting CNE credit:
• Review the critical areas that affect nonadherence to antipsychotic medication and define strategies to address adherence.
• Describe the available measurement-based tools to evaluate patients’ progress that can be used regularly in practice.
• Recognize the necessity for regular metabolic screening for patients taking antipsychotic medication.
CME Outfitters
Location:
Online
Course faculty:
Henry A. Nasrallah, MD (Moderator)
Professor of Psychiatry and Neuroscience
University of Cincinnati College of Medicine
Cincinnati, OH
Leslie Citrome, MD, MPH
Professor, Department of Psychiatry
NYU Medical Center
New York, NY
Diana O. Perkins, MD, MPH
Professor, Department of Psychiatry
Medical Director, Outreach and Support Intervention Services (OASIS)
University of North Carolina
Chapel Hill, NC
Number of Credits:
1.0 AMA PRA Category 1 Credit™
Link
Detailed Description:
This neuroscience CME Live and On Demand activity will support clinicians to become increasingly proactive in managing adherence and in monitoring their patients with schizophrenia for both clinical progress and optimal outcome. The goal is to implement actionable strategies to integrate measurement-based care and improve adherence to antipsychotic medications. This educational activity is intended for physicians, physician assistants, nurses, nurse practitioners, pharmacists, psychologists, social workers, certified case managers, and other nonphysician health care professionals with an interest in schizophrenia.
Learning Objectives:
At the end of this CME/CE activity, participants should be able to:
• Define the critical areas that affect nonadherence to antipsychotic medication and implement strategies to address adherence in patients with schizophrenia.
• Review the available tools to evaluate patients’ progress and implement regular, measurement-based evaluations.
• Implement regular metabolic screening for patients taking antipsychotic medication.
The following learning objectives pertain only to those requesting CNE credit:
• Review the critical areas that affect nonadherence to antipsychotic medication and define strategies to address adherence.
• Describe the available measurement-based tools to evaluate patients’ progress that can be used regularly in practice.
• Recognize the necessity for regular metabolic screening for patients taking antipsychotic medication.
where
Comments
